scholarly journals The Online “Expert-Panel” – Review of a Novel Web-seminar Format

2021 ◽  
Vol 7 (2) ◽  
pp. 453-455
Author(s):  
Patricia Mattis ◽  
Birgit Habenstein ◽  
Thomas Wittenberg
Keyword(s):  
Clinical Practice ◽  
Applied Research ◽  
Expert Panel ◽  
German Society ◽  
Medical Community ◽  
Home Office ◽  
Surgical Interventions ◽  
Interdisciplinary Knowledge ◽  
Panel Review ◽  
Scientific Interaction

Abstract Since 2021, the Fraunhofer Institutes ITEM and IIS and the German Society for Biomedical Engineering (VDE DGBMT) have launched a new online seminary. This sustainable format, referred to as "Expert Panel", stimulates scientific interaction by introducing research topics and innovations within sixty minutes. The panel with three experts from different fields presents and discusses perspectives from science, clinical practice, and the industry. The first season of the "Expert Panel" offered comprehensive insights on the latest developments and innovations within "New Interventional Methods for Tomorrow's Hearing". Each topic was presented by a triad of experts from science, clinical practice, as well as the industry. The sessions comprised life-demonstration of planning tools for surgical interventions, the presentation of patient-individual intervention techniques and novel audiological systems for Cochlea Implant (CI) fitting and many more inspiring technologies. Each “Expert Panel” concluded with a moderated Q&A final. The sessions provided condensed updates and unique insights from applied research and had a lively attendance of up to more than 120 participants from the fields of research, clinic, and industry. This kind of format does not only drive interpersonal and interdisciplinary knowledge transfer - especially in times of home office - it also enables establishing a community of network partners, who meet at the “Expert Panel” on a regular basis. In addition, education credits have been offered to the medical community, thus creating additional benefit for the participants.

scholarly journals Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Liver Cancer ◽  
2021 ◽  
pp. 1-43
Author(s):  
Masatoshi Kudo ◽  
Yusuke Kawamura ◽  
Kiyoshi Hasegawa ◽  
Ryosuke Tateishi ◽  
Kazuya Kariyama ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Practice ◽  
Public Relations ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Expert Panel ◽  
Clinical Practices ◽  
Fourth Edition ◽  
Level Of Evidence ◽  
Consensus Statements

The Clinical Practice Manual for Hepatocellular Carcinoma was published based on evidence confirmed by the Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma along with consensus opinion among a Japan Society of Hepatology (JSH) expert panel on hepatocellular carcinoma (HCC). Since the JSH Clinical Practice Guidelines are based on original articles with extremely high levels of evidence, expert opinions on HCC management in clinical practice or consensus on newly developed treatments are not included. However, the practice manual incorporates the literature based on clinical data, expert opinion, and real-world clinical practice currently conducted in Japan to facilitate its use by clinicians. Alongside each revision of the JSH Guidelines, we issued an update to the manual, with the first edition of the manual published in 2007, the second edition in 2010, the third edition in 2015, and the fourth edition in 2020, which includes the 2017 edition of the JSH Guideline. This article is an excerpt from the fourth edition of the HCC Clinical Practice Manual focusing on pathology, diagnosis, and treatment of HCC. It is designed as a practical manual different from the latest version of the JSH Clinical Practice Guidelines. This practice manual was written by an expert panel from the JSH, with emphasis on the consensus statements and recommendations for the management of HCC proposed by the JSH expert panel. In this article, we included newly developed clinical practices that are relatively common among Japanese experts in this field, although all of their statements are not associated with a high level of evidence, but these practices are likely to be incorporated into guidelines in the future. To write this article, coauthors from different institutions drafted the content and then critically reviewed each other’s work. The revised content was then critically reviewed by the Board of Directors and the Planning and Public Relations Committee of JSH before publication to confirm the consensus statements and recommendations. The consensus statements and recommendations presented in this report represent measures actually being conducted at the highest-level HCC treatment centers in Japan. We hope this article provides insight into the actual situation of HCC practice in Japan, thereby affecting the global practice pattern in the management of HCC.

scholarly journals Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

2017 ◽  
Vol 75 (9) ◽  
pp. 731-767 ◽  
Author(s):  
Arrigo F G Cicero ◽  
Alessandro Colletti ◽  
Gani Bajraktari ◽  
Olivier Descamps ◽  
Dragan M Djuric ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Expert Panel ◽  
Position Paper ◽  
Lipid Lowering

scholarly journals P14.114 Tumor treating fields in glioblastoma clinical practice guidelines: a European and North American landscape analysis

2019 ◽  
Vol 21 (Supplement_3) ◽  
pp. iii95-iii95
Author(s):  
A Lawson McLean ◽  
R Kalff ◽  
J Walter
Keyword(s):  
Clinical Practice ◽  
Electric Fields ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Medical Oncology ◽  
German Society ◽  
Landscape Analysis ◽  
Science Literature ◽  
Tumor Treating Fields ◽  
Care Protocol

Abstract BACKGROUND Tumor treating fields (TTFields) are low-intensity alternating electric fields delivered at intermediate frequencies to disrupt cancer cell division and inhibit tumor growth, with significantly longer mean lifetime survival of 1.8 additional years in glioblastoma (GBM). International, national and local clinical practice guidelines have implications for clinical, personal and policy decision-making. Furthermore, they may impact on patients’ decisions to choose treatment at a given institution or even lead to commencement of legal proceedings for withholding therapies recommended by international guidelines. We performed an in-depth landscape analysis of clinical practice guidelines for GBM in Europe and North America to explore variation in treatment recommendations with a specific focus on TTFields. MATERIAL AND METHODS A systematic search was conducted of web sites of international guideline developers, relevant cancer agencies and the MEDLINE and Web of Science literature databases. The following information was extracted from each document meeting the inclusion criteria: whether TTFields is discussed and/or recommended in the guideline, the indications for and role of TTFields in the care protocol, the strength of the recommendation and any constraints placed on the situations where this therapy can or may be offered, including on cost grounds, where applicable. Dates of production and validity periods of the guidelines were also noted. In addition, standard operating procedures (SOPs) from several accredited comprehensive cancer centres in Germany, covering GBM care are compared, with a series of clinical vignettes presented. RESULTS The guidelines produced by the National Comprehensive Cancer Network (USA), National Institute for Health and Care Excellence (UK), German Society for Neurology, German Society for Haematology and Medical Oncology, European Association for Neuro-Oncology and European Society for Medical Oncology were critically compared. Wide variation in recommendations relating to the TTFields therapy was observed. Many guidelines had not been updated to reflect the results of the EF-14 study. CONCLUSION Discrepancy in the adoption of TTFields across clinical practice guidelines and SOPs has potential implications for care practices. This ultimately affects patient outcomes, safety and quality of care. Ideally, guidelines should be updated dynamically when new evidence indicates a need for a substantive change in the guideline based on a priori criteria. An ongoing revision process for guidelines, perhaps with shorter validity periods or a more flexible approach, may facilitate more expedient adoption of novel therapies in clinical practice guidelines and in practice. Meanwhile, therapies significantly improving OS and PFS should be recommended to patients and this should be documented.

scholarly journals Radical Dorsal Interventions in Treatment of Kyphotic Deformities (Literature Review)

2015 ◽  
Vol 22 (2) ◽  
pp. 66-75
Author(s):  
M. V Mikhailovskiy ◽  
V. V Novikov ◽  
I. G Udalov
Keyword(s):  
Clinical Practice ◽  
Literature Review ◽  
Vertebral Column ◽  
Surgical Techniques ◽  
Pedicle Subtraction Osteotomy ◽  
Treatment Results ◽  
Vertebral Column Resection ◽  
Surgical Interventions ◽  
Ponte Osteotomy ◽  
Spine Deformities

Widely used in clinical practice surgical interventions directed to the correction of severe kyphotic spine deformities, i.e. Ponte osteotomy, Smith-Peterson osteotomy, pedicle subtraction osteotomy and vertebral column resection are presented. Surgical techniques, surgery planning based on spinal and pelvic sagittal contour parameters, treatment results are described.

scholarly journals Bioresorbable collagen materials in surgery: 50 years of success

2020 ◽  
Vol 11 (1) ◽  
pp. 59-70
Author(s):  
A. L. Fayzullin ◽  
A. B. Shekhter ◽  
L. P. Istranov ◽  
E. V. Istranova ◽  
T. G. Rudenko ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Connective Tissue ◽  
World Literature ◽  
Medical Community ◽  
Keen Interest ◽  
Medical Products ◽  
Handling Characteristics ◽  
Current State ◽  
Over Time

Collagen materials are widely applied in medicine due to optimal handling characteristics, biocompatibility, controlled biodegradation, the ability to form complexes with drugs and facilitate regeneration. Researchers from Sechenov University developed, studied in experiments and introduced into medicine a variety of materials based on collagen — a protein of connective tissue. At the same time, new collagen materials were launched into clinical practice abroad. In this review of Russian and world literature, we described how scientific and applied studies of collagen materials developed over time and tried to illustrate the current state and trends of collagen application for a variety of medical purposes — from hemostatic sponges to tissue-engineered constructs. The range of available collagen-based medical products and the emergence of new collagen materials indicate the keen interest in this biomaterial from the medical community and the potential of future discoveries.

scholarly journals Experience of application of topichesky naturopathic means for patients with ent pathology

2019 ◽  
pp. 33-37
Author(s):  
G. N. Nikiforova ◽  
V. M. Svistushkin ◽  
L. S. Karapetian
Keyword(s):  
Clinical Practice ◽  
Surgical Interventions ◽  
Arnica Montana ◽  
Analgesic Effects ◽  
Reactive Changes ◽  
Inflammatory Processes ◽  
Post Traumatic ◽  
Reparative Effect ◽  
Anti Inflammatory ◽  
Reactive Processes

Post-traumatic reactive changes in the area of ENT-organs can cause cosmetic defects, contribute to the development of infectious and inflammatory processes. The formation of limited edema and bruising is natural after certain even adequately performed surgical interventions. In clinical practice, the question arises of the effective and safe use of local drugs that have anti-inflammatory, anti-edema and analgesic effects to accelerate the course of post-traumatic reactive processes. Naturopathic agents have high safety, sufficiently pronounced anti-inflammatory, analgesic and reparative effect. The drug based on arnica mountain (Arnica montana) is a unique topical drug that only contains fresh Arnica plants in a concentration of 7% TM. Efficiency and high safety of this drug allows us to recommend it for the treatment of bruises and hematomas of the skin in the area of ENT-organs, including after surgical interventions.

Sign in / Sign up

Export Citation Format

Share Document